iCoreConnect Inc. (NASDAQ:ICCT) Sees Large Decline in Short Interest

iCoreConnect Inc. (NASDAQ:ICCT) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 40,600 shares, a drop of 84.1% from the February 28th total of 254,700 shares. Approximately 2.4% of the shares of the company are sold short. Based on an average daily trading volume, of 794,400 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iCoreConnect stock. Virtu Financial LLC purchased a new stake in iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned 1.04% of iCoreConnect at the end of the most recent quarter. 13.42% of the stock is currently owned by institutional investors.

iCoreConnect Price Performance

Shares of NASDAQ ICCT traded down $0.06 during mid-day trading on Friday, reaching $0.30. The company had a trading volume of 3,476,344 shares, compared to its average volume of 378,026. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11. iCoreConnect has a one year low of $0.25 and a one year high of $35.80. The firm has a market cap of $615,888.30, a price-to-earnings ratio of 0.00 and a beta of 1.09. The business’s 50-day simple moving average is $1.51 and its 200 day simple moving average is $3.72.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.